Atorvastatin (ATR) is a poorly soluble anti-hyperlipidemic drug. The drug belongs to the class II group according to the biopharmaceutical classification system (BCS) with low bioavailability due to its low solubility. Solid dispersions adsorbate is an effective technique for enhancing the solubility and dissolution of poorly soluble drugs.
Introduction
The solubility of drug molecules is a significant determinant of the dissolution rate because of dissolution rate is closely tied to solubility (1) . Poor solubility and low dissolution rate of poorly water -soluble drugs in the aqueous gastrointestinal fluids often cause poor bioavailability, Principally for class II drugs, the enhancement of the solubility and dissolution rate of the drug in the gastrointestinal fluids may improve the bioavailability, For BCS class II drugs, the release from the dosage form and solubility in the gastric fluid are the rate-limiting steps rather than their absorption (2) .
Atorvastatin calcium (ATR) is [C33H35FN2O5]2.Ca.3H2O as an empirical formula, and Chemical structure is shown in figure 1 (3) .
Figure 1. Chemical structure of atorvastatin calcium (3)
Atorvastatin calcium (ATR) is an antihyperlipidemic agent able to lowering blood cholesterol levels by the reversible inhibition of HMG-CoA reductase, a rate-limiting step in the cholesterol biosynthesis. It represents one of the most widely administered oral statins used in case of elevated plasma levels of cholesterol, triglycerides, low-density lipoproteins in addition to its ability to elevate the high-density lipoproteins (4) . ATR belongs to BCS class II drug (5) . The drug is very slightly soluble in distilled water with the pKa value of 4.46 and Log p values of 6.36 in octanol/water. It has an absolute oral bioavailability of 12 %. The poor oral bioavailability is attributed to presystemic clearance in the gastrointestinal mucosa and high hepatic first-pass metabolism (6) . Many authors have worked to improve the solubility and dissolution rate of ATR by preparing microsphere, emulsion, nanosuspension, self-microemulsion, solid dispersion (7) .
Solid dispersion (SD) is the most generally used technique for bioavailability enhancement of poorly water-soluble drugs, as the drug dispersed in freely soluble carrier (8) .
Some difficulties limiting the commercial use of solid dispersion such as; formulation into dosage forms(Poor flow, poor compressibility and a requirement of a large quantity of carrier), the scaleup of production processes. In addition, phase separation, crystal growth during storage are also considered to be significant problems to commercialise solid dispersions since the solubility and hence dissolution rate may be decreased during storage (9, 10) .
Solid dispersion adsorbate(SDA) is a technique in which SD is adsorbed onto hydrophilic adsorbent which has an exceedingly high surface area to form a free-flowing powder and to achieve improved solubility, dissolution rates and hence bioavailability (11) .
The effect of adsorbent will help in commercialisation of SD as a tablet or capsule dosage form by improving poor compressibility by adsorbing the SD onto a free-flowing carrier. On the other hand, the stability problem can be reduced by the use of novel excipient like Neusilin® which along with improving the flow property also inhibits the conversion of amorphous form back to the crystalline form by entrapping the molecularly dispersed drug into its porous network (12) . Other adsorbents were also used, including Aerosil, Florite, and Sylysia having different characteristics such as particle size, pore size, and specific surface area (13) .
The aim of this study was to enhance the solubility and dissolution rate of ATR by solid dispersion adsorbate technique using Polyethylene glycol (PEG)4000 and 6000 or poloxamer188 and 407 as a hydrophilic carrier and Magnesium aluminium silicate (MAS) or Aerosil200 or Aerosil 300 as adsorbents.
Materials and Method

Materials
Atorvastatin calcium(ATR), Aerosil200 and PEG 6000 were supplied by Pioneer pharmaceutical company, Iraq as a gift sample. Poloxamer188, polxamer407, Magnesium aluminium silicate (MAS) and aerosil300 were purchased from Hangzhou, Hyperchem. China. PEG 4000 was purchased CDH, India.
Method Preparation of solid dispersion of atorvastatin calcium
Solid dispersions of ATR were prepared using a melting method. In this method,the carrier (PEG4000, PEG 6000, Poloxamer 188 or poloxamer 407) is melted using water bath at its corresponding melting point, and the drug was then incorporated into the molten carrier mass in a ratio of 1:1 with constant stirring. The blend was cooled at room temperature. The solid dispersion was pulverised through a 60 mesh sieve and stored in the desiccator for further use (14) . The prepared solid dispersions are shown in table 1.
Preparation of solid dispersion adsorbate (SDA) of atorvastatin calcium
Solid dispersion adsorbate of ATR was prepared by addition of the drug to melt of each carrier individually in porcelain dish on a water bath at 60˚C and mixed. Once homogeneous slurry was obtained, the adsorbent ( Aerosil 200, Aerosil 300 or MAS.) was added and stirred until the blend was converted to mass. The drug to a carrier to adsorbent ratio was fixed at 1:1:1 (Table 2 ). Finally, the mass was allowed to cool at room temperature. The SDAs were passed through a 60 mesh sieve to obtain a free-flowing powder of uniform size (15) . 
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Preparation of physical mixture (PM)
The PM was prepared by uniform mixing of drug, carrier and adsorbent in the same ratios of SDA. The mixing powder was passed through a sieve 60 mesh to get uniformly sized particles (16) . 
Evaluation of SD and SDA Determination of saturation solubility
An excess amount of ATR, SD and SDA were added to 10 ml of water; the samples were incubated in water bath shaker at 25 ˚C for 48 hr. after that, the samples were filtered through a 0.45µm syringe filter and diluted when necessary. The diluted samples were analysed by UV spectrophotometer at 241 nm was used to determine the dissolved quantity of atorvastatin (17) .
Determination of percentage yield (PY %)
The Percentage yield was measured for each type of SD and SDA, which was calculated using equation 1 (18) . (1)
Determination of drug content of SD and SDA
An accurately weighed quantity of SD and SDA equivalent to 10mg of ATR was taken and dissolved in a 10 ml of methanol and volume was made up to 50 ml. From this, 1ml of the solution was taken and further diluted ten times with methanol. The solution was assayed for drug content using UV spectrophotometry method by measuring the absorbance at 247 nm (19) . The percentage of drug content in the SD and SDA was calculated by using equation 2 (20) . Drug content %= Actually gained weight of ATR Theoretical weight of ATR
100
(2)
In-vitro dissolution studies
In-vitro dissolution studies of SDA equivalent to 20mg atorvastatin were carried out in 900 ml phosphate buffer (pH 6.8) in USP apparatus-Type II (PHARMA TEST, Germany) at 37 ± 0.5 ˚C and 75 rpm (21) . Aliquots of 5 ml were withdrawn and then replaced by fresh media of dissolution at regular time intervals, filtered, and was analysed spectrophotometrically at 240nm by UV visible spectrophotometer (Carry win UV, Australia).
X-ray powder diffraction (XRD)
The X-ray powder diffraction spectra of optimised formula, PM, and ATR were recorded using Shimadzu X-diffractometer(Model: XRD-6000, Japan). Samples were pulverised into powders with a mortar and pestle, and the cross-section of samples was exposed to x-ray radiation.The scanning angle ranged from 5 to 80 of 2ө, voltage-40kV and current -40 mA (22) .
Differential scanning calorimetry (DSC)
Differential scanning calorimetry of ATR, optimised formula, PM, carrier and adsorbent were done using DSC60 (Shimadzu, Japan ). Thermal behaviour of the samples was investigated under a scanning rate of 10 ˚C/min, covering a temperature range of 20-200 ˚C under inert atmosphere flushed with nitrogen at a rate of 20 ml/min (23) .
Fourier transform infrared (FTIR)
Fourier Transform Infrared spectra of ATR, MAS, PM and the optimized formula were obtained using Shimadzu, Fourier Transform Infrared Spectroscopy (FTIR 43000), (Japan) , each sample was dispersed in KBr powder, blend well in mortar and pestle, and compressed into transparent discs for FTIR examination and FTIR spectra were recorded in spectra region 4000 to 400 cm -1 at an instrument resolution of 4 cm -1 (24) .
Results and Discussion
Saturation solubility of ATR SDs
Results of saturation solubility studies of ATR SDs are shown in table 3. Significant enhancement in solubility of ATR (p<0.05) was obtained, which may be attributed to the hydrophilic nature of all the used carriers, besides hydrogen bonding that may be formed between ATR and carriers led to enhance the solubility of ATR (25) .The solubility enhancement of the various carriers was found to be in the following descending order: poloxamer407> poloxamer188 > PEG6000>PEG4000. The highest solubility was obtained using poloxamer 407 as a carrier due to the surfactant effect of poloxamer 407 and micelles formation (26) . Table 4 shows the results of solubility ATR SDAs. Further improvement in solubility was obtained when ATR prepared as SDAs in comparison to that obtained by SDs. that can be explained to be due to adsorption of ATR on the hydrophilic adsorbent and increase the surface area of ATR that exposed to the solvent , whereby the drug is bound to the adsorbent and thus cannot agglomerate which results in enhanced wettability of the drug particles and hence its solubility (27, 28) . The solubility enhancement of the various adsorbents was found to be in the following descending order: MAS > Aerosil 300 > Aerosil 200 in the presence of any hydrophilic carrier( figure  2) . The results may be due to the difference adsorption capacity of three adsorbents to the drug. Highest solubility was obtained with MAS because it has excellent disintegrating activity in an aqueous solution (29) and large surface area due to Its composition of many silicate layers and good adsorption properties because of a negative charge on the surface of the silicate layers that brings about a strong electrostatic interaction with a cationic drugs and the silanol groups can interact by hydrogen bond with drugs which gives it good adsorption properties (30) . Whereas the difference adsorption capacity of two other adsorbents to the drug can be explained to the difference in their surface area as the surface area of Aerosil 300(300 ±30m 2 /g), so it has high adsorption capacity when compared with Aerosil 200(200 ± 25m 2 /g) (31) . Therefore, the largest surface area of ATR that exposed to the dissolution medium was obtained when it is adsorbed on MAS. Formula SDA12 showed the highest solubility 970.8±0.0274 µg/ml compared to 120.2±0.0138 µg/ml for pure drug and 180.34µg/ml solid dispersion(SD4) (ATR: Poloxamer407 1:1) indicating that solid dispersion adsorbate technique enhances the solubility by 8.07 and 5.38 fold as compared to the pure drug and ordinary SD respectively. (1:1:1) on the solubility of ATR in distilled water at 25°C
Saturation solubility of ATR SDAs
Figure2. Effect of adsorbent and carrier type of ATR SDA at ratio
Determination of percentage yield (PY %) and content of prepared SD and SDA
The prepared SDs and SDAs formulas showed high percentage yield ranged between 85.5-98.53%. This result indicating the suitability of the method (melting or melt adsorption method) with the used material for such preparations.
On the other hand, the drug content in all the formulations was found to be within 98-100% w/w, which is in agreement with U.S.P requirements (98-102%) (21) . The results of percentage yield and drug content are shown in table 5. 
In-vitro dissolution studies
Comparative in-vitro dissolution of the pure drug, SDA12 (ATR:poloxamer407: MAS 1:1:1) ,SD4(ATR:polxamer407 1:1)and physical mixture(PM) of SDA12 was studied The similarity factor ( 2) was used to consider similar dissolution profiles (equation 3).
= 50 × log { [1 +
Where (n) is the number of dissolution time points. (Rt) and (Tt) is the reference and test dissolution values at time t.
The two dissolution profiles consider similar when f2 values higher than 50 (50-100); otherwise, the profiles are not similar (32) .
An improvement in the dissolution was obtained (figure 3) by SDA12 in comparison with SD4 (f2=48.55), PM of SDA12 formula ( f2=40.23) and pure drug (f2=27.26). This result can be due to increased solubility by the formation of hydrogen bonding between the drug and MAS, micellar solubilisation of ATR in poloxamer407, improved wettability and amorphisation of ATR (33) . That needs further investigation by FTIR, XRD and DSC. 
X-ray powder diffraction (XRD)
The XRD diffractogram of ATR, SDA 12 and PM are shown in Figure 4 . The diffraction pattern of the pure drug showed characteristic highintensity peaks at 9.06, 9.38, 10.17, 11.74, 16.89, 19.32, 21.48, 22.5549, 23.17 and 23.57, which indicates that the drug is present in the crystalline form that is also confirmed by DSC results. Physical mixture's pattern showed the characteristic peaks of ATR with lower intensity compared to the pure drug. This result can be explained to be due to the dilution effect of the carrier. In contrast, Further decrease or absence of the characteristic peaks of ATR was observed with SDA 12, indicating that an amorphous form mostly exists in solid dispersion adsorbate (34, 35) . This amorphous form may contribute to solubility improvement since this form is more easily soluble than the crystalline form.
Figure4. X-ray diffractograms of ATR(A), PM (B)and solid dispersion adsorbate of selected formula SDA12 (C)
Differential scanning calorimetry (DSC)
Thermograms of ATR, MAS, Poloxamer407, PM and the SDA12 are shown in figure 9 , respectively. The DSC curve of ATR gives an endothermic peak corresponding to its melting point at 160.04˚C; the result indicated the purity and crystallinity of the used ATR. (6) While the DSC of MAS shows no endothermic peak in the studied DSC temperature range and Poloxamer407 shows an endothermic peak at 53.80 ˚C correspondings to its melting point (36) . PM shows the only distinct peaks of Poloxamer407 with a decrease in intensity and melting point to 47.04˚C which may be due to dilution with other components while the absence of ATR peak may be due to adsorption of the drug on MAS (37) which will be confirmed by FTIR study. The thermogram of SDA12 shows further decrease in the intensity of poloxamer 407 with disappearance of ATR peak which may be due to adsorption effect and its complete dispersion in the melted polymer and conversion of the drug from crystalline to amorphous state (38) .
Fourier transform infrared (FTIR)
The ATR exhibits characteristic peaks at 3664cm -1 (free O-H stretching),3365cm -1 (O-H stretching),3278cm -1 and 3060cm -1 (N-H stretching multiple band),2966 cm -1 (C-H stretching), 1651cm -1 (amide C=O stretching), 1581 cm -1 (aromatic C=OC stretching) , 1516 cm -1 (N-H bending),812 cm -1 (out of plane N-H wagging) were found in the crystalline form (Unprocessed drug) as shown in figure 6 (39,3) .The FTIR Spectrum of PM showed the characteristic peak of ATR with low intensity indicates the predominant effect of carrier and adsorbent concentration (40) .
The spectrum of the SDA15 showed broad and weak O-H stretch peak (3365 cm -1 ) and N-H stretching multiple bands compared to atorvastatin crystalline drug. Besides, a broad peak or absent peak corresponding to a hydroxyl stretching of MAS SiOH 3620cm -1 that may be due to the formation of a hydrogen bond between silanol group on the surface of MAS and hydroxyl group and amide group of ATR (39, 01) .
The carboxyl stretching peaks at 1651 and 1581 cm -1 of ATR shifted to higher wavenumber(1655 and 1589) cm -1 and presented lower intensity in SDA12 (figure10, D), indicating an electrostatic interaction of carboxyl group of ATR with the positively charged sites in the edges of MAS structure (37) .
The most characteristic peaks of ATR are still present but some decrease in intensity and shifting of some peak, this indicates that there was no chemical incompatibility between drug, carrier and adsorbate otherwise it confirm the adsorption process. 
Conclusion
An improvement in solubility and dissolution of ATR was obtained by preparing it as solid dispersion adsorbate by melt adsorption method using hydrophilic carriers and adsorbents in a ratio of 1:1:1(drug: carrier: adsorbent).
All prepared formula of SDAs improved the solubility of ATR may be due to increased wettability and reduced crystallinity of the drug, which leads to improve drug solubility and dissolution.
However, Maximum solubility with enhanced dissolution was obtained by SDA12 using poloxamer 407 as a hydrophilic carrier with surfactant effect and MAS as an adsorbent with high surface area.
